<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liew CW</submitter><funding>NIBIB NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>FIC NIH HHS</funding><pagination>2876-88</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2912176</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>120(8)</volume><pubmed_abstract>Insufficient insulin secretion and reduced pancreatic beta cell mass are hallmarks of type 2 diabetes (T2DM). Here, we confirm that a previously identified polymorphism (rs2295490/Q84R) in exon 2 of the pseudokinase-encoding gene tribbles 3 (TRB3) is associated with an increased risk for T2DM in 2 populations of people of mixed European descent. Carriers of the 84R allele had substantially reduced plasma levels of C-peptide, the product of proinsulin processing to insulin, suggesting a role for TRB3 in beta cell function. Overexpression of TRB3 84R in mouse beta cells, human islet cells, and the murine beta cell line MIN6 revealed reduced insulin exocytosis, associated with a marked reduction in docked insulin granules visualized by electron microscopy. Conversely, knockdown of TRB3 in MIN</pubmed_abstract><journal>The Journal of clinical investigation</journal><pubmed_title>The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells.</pubmed_title><pmcid>PMC2912176</pmcid><funding_grant_id>R03 TW001351</funding_grant_id><funding_grant_id>P30 DK36836</funding_grant_id><funding_grant_id>R01 DK082582</funding_grant_id><funding_grant_id>R01 DK47475</funding_grant_id><funding_grant_id>R01 DK047475</funding_grant_id><funding_grant_id>1RL9EB008539-01</funding_grant_id><funding_grant_id>RL9 EB008539</funding_grant_id><funding_grant_id>P30 DK036836</funding_grant_id><funding_grant_id>R01 DK067536</funding_grant_id><funding_grant_id>R01 DK 67536</funding_grant_id><funding_grant_id>R01 TW01351</funding_grant_id><pubmed_authors>Bochenski J</pubmed_authors><pubmed_authors>Krolewski AS</pubmed_authors><pubmed_authors>Kawamori D</pubmed_authors><pubmed_authors>Qi L</pubmed_authors><pubmed_authors>Warram JH</pubmed_authors><pubmed_authors>Hu J</pubmed_authors><pubmed_authors>Leech CA</pubmed_authors><pubmed_authors>Malecki M</pubmed_authors><pubmed_authors>Kulkarni RN</pubmed_authors><pubmed_authors>Liew CW</pubmed_authors><pubmed_authors>Wanic K</pubmed_authors></additional><is_claimable>false</is_claimable><name>The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells.</name><description>Insufficient insulin secretion and reduced pancreatic beta cell mass are hallmarks of type 2 diabetes (T2DM). Here, we confirm that a previously identified polymorphism (rs2295490/Q84R) in exon 2 of the pseudokinase-encoding gene tribbles 3 (TRB3) is associated with an increased risk for T2DM in 2 populations of people of mixed European descent. Carriers of the 84R allele had substantially reduced plasma levels of C-peptide, the product of proinsulin processing to insulin, suggesting a role for TRB3 in beta cell function. Overexpression of TRB3 84R in mouse beta cells, human islet cells, and the murine beta cell line MIN6 revealed reduced insulin exocytosis, associated with a marked reduction in docked insulin granules visualized by electron microscopy. Conversely, knockdown of TRB3 in MIN</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Aug</publication><modification>2026-04-30T11:23:04.139Z</modification><creation>2019-03-27T00:32:47Z</creation></dates><accession>S-EPMC2912176</accession><cross_references><pubmed>20592469</pubmed><doi>10.1172/JCI36849</doi><doi>10.1172/jci36849</doi></cross_references></HashMap>